A lawsuit alleges St. Bernard Parish Hospital failed to notify a patient for more than a month after she was allegedly ...

SPXL sells a simple promise: three times the daily move of the S&P 500. What its factsheet does not sell is the quiet gap that opens between that promise and reality every time markets zigzag. That ...

Kennedy Jr.'s recent push to expand access to peptides, FDA career scientists determined there isn't adequate evidence to support any of the ones under consideration for production by compounding ...

Parents weighing tax-advantaged savings vehicles for their children are increasingly comparing newly launched Trump Accounts against custodial Roth IRAs, a vehicle that has been available for decades.

Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding Pharmacies.

The FDA has listed its advisory members for the committee that will discuss peptides in late July. Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some ...

The stock is already showing accelerating fundamentals (33% LTM revenue growth, 73% gross margin) plus credible weight-loss distribution via Novo Nordisk’s largest telehealth partner. The market is ...

Hims & Hers Health (HIMS) stock, Replimune (REPL) stock, and Capricor (CAPR) stock are in focus as the FDA brings back Advisory Committee meetings. Read more here.

Splitero reports that homeowners with fair credit face challenges accessing home equity, as lending standards vary by state, impacting approval rates.

A major supplier of sterile hospital drugs is packing up operations in southwest Phoenix, and it is taking 116 paychecks with it. Central Admixture Pharmacy Services Inc. is shutting down its 503B ...

SCHD is no longer an attractive long-term allocation, given recent reconstitution and macro dynamics favoring growth assets. Read more on SCHD ETF here.

Every business searches for an advantage. Some invest heavily in technology. Others focus on expansion, acquisitions or product innovation. Many pursue efficiency through automation or seek new ...